Full List Of Stories
World Cup preview: Colombia v Japan, Poland v Senegal, Russia v Egypt
As the dust settles on the manic celebrations or commiserations that follow England’s opening match against Tunisia, Tuesday brings the final first round matches along with the hosts’ second match.
Empyrean Energy completes offshore oil migration study in China
Oil and gas firm Empyrean Energy on Monday completed an oil migration study for offshore China Block 29/11, a site with potential pathways into the Jade, Topaz and Pearl prospects.
European Wealth Group appoints PhotonStar chairman to board
Investment management company European Wealth Group (EWG) on Monday appointed Jonathan Freeman to its board as a non-executive director.
Cabot Energy sees raft of changes as High Power Petroleum populates roles
Cabot Energy on Monday appointed Scott Aitken as chief executive amid a slew of changes, including Keith Bush and Nicholas Morgan stepping down from their respective roles as chief executive and finance director.
OptiBiotix Health scoops manufacturing and supply deal with Morley Foods
Life sciences firm OptiBiotix Health on Monday entered into an exclusive manufacturing and supply agreement with John Morley Foods for weight management technology SlimBiome.
Venture Life increases distribution across Boots stores
Venture Life Group increased distribution of its oral hygiene brand UltraDEX’s products in the UK with Boots by 46%, with the high street chemist launching two of its new products.
Swedish Democrat Party sets sights on EU referendum
Sweden's third largest party is pushing for a referendum on leaving the European Union within the next four years.
Savannah Petroleum appoints ex-BP man to operations chief role
Africa-focused oil and gas firm Savannah Petroleum on Monday appointed current non-executive director David Clarkson as chief operating officer with immediate effect.
hVIVO soars on trial success for universal influenza vaccination
hVIVO on Monday confirmed it has seen positive final results from its clinical trial of the safety and efficacy of two formulations and dosing regimens of FLU-v vaccine administered in healthy adults.